	Integrating inflammatory and coagulation biomarkers for surgical risk stratification and treatment benefit assessment in Crohn's disease. Front Immunol Xie K, Sun Q, Yang L, Jiang Z, Liu H, Zhang Y, Yao H, Wu Q, Yao B, Peng L, Zhang D, Yuan L. PMID: 42183243 [PubMed - indexed for MEDLINE]
	Outcomes of Difficult-to-Treat Ulcerative Colitis: Impact of Primary Nonresponse vs Secondary Loss of Response to Prior Therapies: A Retrospective Cohort Study. Gastro Hep Adv Lou T, Qi Y, Kirkpatrick M, Boland BS, Singh S. PMID: 42181856 [PubMed]
	The UCEIS and UC-100 score were responsive endoscopic and global indices in a phase 2 trial of ulcerative colitis. Crohns Colitis 360 Vuyyuru SK, Travis S, Kiarasi S, Zou G, Lagana S, Schaeffer DF, Arora V, Tuttle JL, Ma C, Jairath V. PMID: 42180013 [PubMed]
	Endoscopic Outcomes of Risankizumab in Crohn's Disease: A Real-World Analysis of Terminal Ileal Lesions. Inflamm Intest Dis Uchiyama K, Takagi T, Obata R, Murakami E, Asaeda K, Kajiwara-Kubota M, Hotta Y, Tanaka M, Inoue K, Omatsu T, Katada K, Naito Y. PMID: 42179645 [PubMed]
	Prognostic value of novel serological markers in predicting postoperative complications of ileocecal resection in Crohn's disease patients. Pol Przegl Chir W, St, Prusisz M, Mary, Bili, W, Dziki . PMID: 42178956 [PubMed - indexed for MEDLINE]
	Impact of sarcopenia on postoperative outcomes and recurrence in patients with Crohn disease: A retrospective cohort study. Medicine (Baltimore) Yi GH, Lee JL, Kim KW, Kim CW, Yoon YS, Park IJ, Lim SB, Yu CS. PMID: 42175457 [PubMed - indexed for MEDLINE]
	Uncovering Topics in Dutch Patient Messages in Inflammatory Bowel Disease: A Comparative Study of Embedding Models for Neural Topic Modeling. Stud Health Technol Inform Zhang J, Puts S, Hendrix E, Aliu A, Okegunna Y, Wintjens D, Mujagi, Dekker A, Pierik M, Fijten R. PMID: 42175024 [PubMed - indexed for MEDLINE]
	The cAMP response element modulator (CREM) in Ulcerative colitis: Molecular mechanisms and therapeutic potential. Biochem Pharmacol Hui X, He Z, Feng Y, Du Y, Chen T, Du J, Huang Y, Wang F, Cheng X. PMID: 42173408 [PubMed - as supplied by publisher]
	Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial. Clin Gastroenterol Hepatol Yao J, Wu H, Wu L, Yu Q, Cao X, Xie T, Zhong X, Chen H, Wu J, Liu X, Shi L, Zhang M, Peng X, Deng J, Wang W, Liu T, Su T, Yang H, Xia D, Zhi M. PMID: 42173298 [PubMed - as supplied by publisher]
	Does inflammatory bowel disease play a role in cognitive decline? A systematic review. J Crohns Colitis Motisi Bertulli A, Bezzio C, Marsano S, Corradini I, Stranges S, Matteoli M, Armuzzi A. PMID: 42172661 [PubMed - indexed for MEDLINE]
	Impact of rheumatologic diseases on pediatric inflammatory bowel disease. Turk J Pediatr Demirta, Sa, H, Bal, Salt, Özen H, Demir H, Özen S. PMID: 42172463 [PubMed - indexed for MEDLINE]
	Ustekinumab in the Management of Perianal Fistulizing Crohn's Disease: Current Evidence and Practical Strategies. Drugs R D Yang B. PMID: 42171988 [PubMed - as supplied by publisher]
	Comparative effectiveness of mirikizumab and risankizumab in patients with ulcerative colitis: A propensity-matched cohort study. Indian J Gastroenterol Kochhar GS, Dulai PS, Khataniar H, Desai A. PMID: 42171975 [PubMed - as supplied by publisher]
	Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trial. J Crohns Colitis Bhandari M, Sharip MT, Noor NM, Khwaja S, Paverd H, De Paepe KN, Godfrey E, Hickman K, Patel KV, Subramanian S, Raine T, Lee JC, Kennedy NA, Upponi S, Parkes M, PROFILE Study Group. PMID: 42171376 [PubMed - indexed for MEDLINE]
	Epigenetic biomarkers in inflammatory bowel diseases-computational challenges and opportunities. J Crohns Colitis Lee S, Park J, Lee HC, Xu X, Slater E, Gasparetto M, Han N, Zilbauer M. PMID: 42171375 [PubMed - indexed for MEDLINE]
	Intestinal cancer risk in Crohn's disease: reporting, eligibility, and inference considerations in a meta-analysis. J Crohns Colitis Zhang X, Yue C. PMID: 42171374 [PubMed - in process]
	Anti-TNF Drug-Induced Sarcoidosis in Inflammatory Bowel Diseases: Multicentric Case Series and Literature Review. Biomed Res Int Bez P, Chkolnaia Z, Aratari A, Ascolani M, Bacsur P, Blesl A, Seksik P, Nikolic S, Edoardo V S, Rattazzi M, Cinetto F, Felice C. PMID: 42170754 [PubMed - indexed for MEDLINE]
	Unveiling Genital Crohn's Disease: Clinical Complications, Diagnosis, and Treatment, a Comprehensive Review of Case Reports. Gastro Hep Adv Fahim B, Elnaggar M, Ebrahim MA, Sapoor S, Helmy A, El-Nasser MA, Mehmood AM, Elshennawy S, Al Komi AS, Shakharteh L, Ashour M, Elkhattib I, Gado M, Soliman E, El Aziz MA, Ghoz H. PMID: 42170673 [PubMed]
	Early Predictors of Steroid Failure in Acute Severe Ulcerative Colitis: A Retrospective Study With the Evaluation of the Admission Model for Intensification of Therapy in Acute Severe Colitis (ADMIT-ASC) Score. Cureus Merzouki O, Mliyahe S, Meyiz H, El Fadli I, Aziz M, Ghannami Y, Ouaya H, Akjay A, Mellouki I. PMID: 42170363 [PubMed]
	TL1A as a therapeutic renaissance in inflammatory bowel disease: a systematic review from molecular mechanisms to clinical translation. J Crohns Colitis Liang RF, Pugliano CL, Hughes R, Majumder S, Lo Bello A, Iacucci M, Ghosh S. PMID: 42166713 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 57700

Page 1 of 2885



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy